Drugs / mRNA-1893
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04064905 | Jul 2019 → Mar 2021 | Zika virus infectious disease | ModernaTX, Inc. | Completed | No outcome recorded |
| Phase 21 trial · 1 met primary | ||||||
| Phase 2 | NCT04917861 | Jun 2021 → Jul 2024 | Zika virus infectious disease | ModernaTX, Inc. | Completed | Met primary |
News releases announcing trial results or a regulatory action · 4
| Date | Issuer | Release |
|---|---|---|
| 2019-11-06 | ModernaTX, Inc. | Regulatory Moderna Provides Business Updates and Reports Third Quarter 2019 Financial Results q4web.com ↗
FDA granted Fast Track designation for Zika vaccine (mRNA-1893) |
| 2019-10-02 | ModernaTX, Inc. | Results Moderna to Present Data From Two of Its Prophylactic mRNA Vaccines at IDWeek 2019 q4web.com ↗
Preclinical data show Zika vaccine (mRNA-1893) protective against Zika virus transmission during pregnancy in mice; |
| 2019-09-12 | ModernaTX, Inc. | Regulatory Moderna Announces Positive Interim Results from Phase 1 Cytomegalovirus (CMV) Vaccine (mRNA-1647) Study and Progress Toward Phase 2 and Pivotal Trials q4web.com ↗
Moderna’s investigational Zika vaccine (mRNA-1893), currently in a Phase 1 study, was recently granted FDA Fast Track designation. |
| 2019-08-19 | ModernaTX, Inc. | Regulatory Moderna Receives FDA Fast Track Designation for Zika Vaccine mRNA-1893 q4web.com ↗
the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its investigational Zika vaccine (mRNA-1893) |
All press releases naming this drug 4 releases
| Date | Issuer | Release |
|---|---|---|
| 2019-11-06 | ModernaTX, Inc. | Moderna Provides Business Updates and Reports Third Quarter 2019 Financial Results q4web.com ↗ |
| 2019-10-02 | ModernaTX, Inc. | Moderna to Present Data From Two of Its Prophylactic mRNA Vaccines at IDWeek 2019 q4web.com ↗ |
| 2019-09-12 | ModernaTX, Inc. | Moderna Announces Positive Interim Results from Phase 1 Cytomegalovirus (CMV) Vaccine (mRNA-1647) Study and Progress Toward Phase 2 and Pivotal Trials q4web.com ↗ |
| 2019-08-19 | ModernaTX, Inc. | Moderna Receives FDA Fast Track Designation for Zika Vaccine mRNA-1893 q4web.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA-1893 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04064905 ↗ |
| Modality | Messenger RNA (mRNA) | “two mRNA-based Zika virus vaccines (mRNA-1325 and mRNA-1893)” PMID 36682364 ↗ Jan 2023 |